Send feedback

GRHL2 p.Tyr139=

c.417C>T · rs768143303 · VCV681159

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0134%, afr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.065GERP 1.4, phastCons 0.67
Overall
CADD2.233PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0134% African / African-American · 10/74,894 alleles
Filtering AF 0.00723% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0055%
Overall 0.00143% 23/1,614,024 alleles · ultra-rare exomes 22/1,461,892 · genomes 1/152,132 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.0134% 7,489
Remaining individualsnot grpmax-eligible 0.0112% 8,927
South Asian 0.0022% 45,529
European (non-Finnish) 0.000339% 295,010

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GRHL2
Protein
p.Tyr139=
Coding
c.417C>T
MANE Select
NM_024915
dbSNP
rs768143303
Type
single nucleotide variant
Location
chr8:101558551 (GRCh38)
Gene constraint
LOEUF 0.367 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 67.46 · 1 PDB
Full GRHL2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/grhl2-p-tyr139 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown